BioKangtai at VIF: Shaping the Future of Global Vaccine Cooperation

From March 20 to 22, 2025, BioKangtai participated in the Vaccine Innovation Forum (VIF) in Shanghai. This premier international event, attended by global vaccine innovators, scientists, and policymakers, is dedicated to advancing vaccine science and global health.  The forum featured over 120 speakers and 1,000+ international delegates from more than 30 countries. BioKangtai engaged with peers and experts, sharing insights and exploring collaborative opportunities.

During the event, BioKangtai presented on “BioKangtai’s Strategy and Technology Transfer Practices in the Era of Global Vaccine Cooperation.” The presentation highlighted the company’s innovative approach to vaccine development and its commitment to enhancing global vaccine accessibility through strategic partnerships and technology transfer.

BioKangtai’s participation in the VIF demonstrated company’s ongoing dedication to driving innovation and fostering international cooperation within the vaccine sector. BioKangtai looks forward to continuing these efforts and contributing to improved global health outcomes.